U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT06875219) titled 'To Evaluate Long- Term Safety and Efficacy of Luspatercept' on Feb. 25.
Brief Summary: An observational study to evaluate long-term safety and efficacy of luspatercept in subjects with transfusion dependent who received the first dose of luspatercept after its introduction in the clinical practice
Study Start Date: April 30, 2023
Study Type: OBSERVATIONAL
Condition:
Thalassemia Major
Intervention:
DRUG: Luspatercept (ACE-536)
Luspatercept (ACE-536)
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Fondazione per la Ricerca sulle Anemie ed Emoglobinopatie in Italia
Published by HT Digital Content Services with permission ...